Pharmacokinetics and Pharmacodynamics Study of Gemcabene in Healthy Volunteers

NCT02587364 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: Gemcabene 50 mg
DRUG: Gemcabene 150 mg
DRUG: Gemcabene 450 mg
DRUG: Gemcabene 750/600 mg
DRUG: Gemcabene 900 mg
DRUG: Placebo

Sponsor

NeuroBo Pharmaceuticals Inc.